ID   CTSC-1
AC   CVCL_W664
DR   Wikidata; Q54814773
RX   Patent=CN103966169A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012176.
CC   Population: Chinese.
CC   Doubling time: 37.52 +- 1.34 hours (Note=At 10th passage), 30.85 +- 0.53 hours (Note=At 30th passage) (Patent=CN103966169A).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Patent=CN103966169A
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 20,21
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14,15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D6S1043: 11,14
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 15,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   Patent=CN103966169A;
RA   Zhang Y., He H., Zhang H.-X., Wang H.;
RT   "Chinese tongue squamous cancer cell line CTSC-1 and establishment
RT   method thereof.";
RL   Patent number CN103966169A, 06-Aug-2014.
//